Financial health overview of pharmaceutical sector companies listed on IDX using profitability ratios before, during, and after the COVID-19 pandemic
DOI:
https://doi.org/10.60036/jbm.1034Keywords:
Profitability Ratios, Pharmaceutical Sector, COVID-19 Pandemic, Indonesia Stock Exchange, Financial HealthAbstract
Purpose – This paper analyzes the financial health of selected pharmaceutical companies listed on the Indonesia Stock Exchange (IDX) using profitability ratios across periods before (2019), during (2020--2021), and after (2022) the Covid-19 pandemic, highlighting sector resilience amid economic shocks.
Design/methodology/approach – A descriptive quantitative approach uses secondary data from audited financial statements of four companies: PT Darya-Varia Laboratoria Tbk (DVLA), PT Pyridam Farma Tbk (PYFA), PT Industri Jamu dan Farmasi Sido Muncul Tbk (SIDO), and PT Tempo Scan Pacific Tbk (TSPC). Profitability ratios include Gross Profit Margin (GPM), Operating Profit Margin (OPM), Net Profit Margin (NPM), Operating Return on Assets (OROA), and Return on Equity (ROE), with peer-group comparisons and DuPont analysis.
Findings – Profitability improved during the pandemic (2020--2021), driven by surging demand for health products. SIDO consistently outperformed peers. PYFA showed a strong recovery in 2022. GPM declined post-pandemic due to rising costs. Overall, the sector demonstrated counter-cyclical resilience.
Research limitations – The study covers only four companies and focuses solely on profitability ratios, excluding liquidity, solvency, or macroeconomic modeling. Suggestions for future research include expanding the sample and incorporating additional metrics.
Implications – Findings inform investors and policymakers on the pharmaceutical sector's resilience during crises and emphasize post-pandemic cost management strategies.
Originality – This study fills a gap by extending profitability analysis into the post-pandemic period (2022) with peer benchmarking, providing a complete trajectory across pandemic phases.
Downloads
References
Badan Pusat Statistik. (2019). Statistik Pertumbuhan Produksi Industri Manufaktur Triwulan IV-2018. In Badan Pusat Statistik (Issue 13).
Brigham, E. F., & Houston, J. F. (2022). Fundamentals of Financial Management (16th ed.). Cengage Learning.
Cintyaningtyas, D. (2017). *Analisis Rasio Keuangan Untuk Menilai Kinerja Keuangan Perusahaan Farmasi Yang Terdaftar Di BEI Tahun 2013-2016* [Universitas Muhammadiyah Surakarta]. https://eprints.ums.ac.id/56163/1/NASKAH PUBLIKASI.pdf
Dikri, P., Putra, P. P., Hidayati, R. N. F., & Irawan, F. (2022). Analisis Kinerja Keuangan Perusahaan Farmasi Sebelum Dan Selama Masa Pandemi Covid-19. Akuntansiku, *1*(4), 269--280. https://doi.org/10.54957/akuntansiku.v1i4.284
Ghozali, I. (2018). Aplikasi Analisis Multivariate dengan Program IBM SPSS 25 (9th ed.). Badan Penerbit Universitas Diponegoro.
Gitman, L. J., & Zutter, C. J. (2015). Principles of Managerial Finance (14th ed.). Pearson.
Indonesia Stock Exchange. (2019). Laporan Keuangan Tahunan 2019. In Idx (Vol. 2, Issue 4). https://jurnal.portalpublikasi.id/index.php/JORAPI/article/view/1180
Indonesia Stock Exchange. (2020). Laporan Tahunan 2020 Annual Report: Digital Capabilities To Advance Further. Idx, 434.
Indonesia Stock Exchange. (2021). Annual Report 2021 - Outperforming Expectations Amidst Uncertainties. Idx, 452. https://www.idx.co.id/id/tentang-bei/laporan-tahunan/
Indonesia Stock Exchange. (2022). Laporan Tahunan 2022 "Maintaining Resilience to Overcome Challenges." Indonesia Stock Exchange, 27.
Kieso, D. E., Weygandt, J. J., & Warfield, T. D. (2019). Intermediate Accounting: IFRS Edition (4th ed.). Wiley.
Kurniawan, A., & Saifi, M. (2021). Dampak Pandemi Covid-19 terhadap Kinerja Keuangan Sektor Farmasi di Bursa Efek Indonesia. Jurnal Ilmiah Akuntansi Dan Bisnis, 16(2), 245–260.
Pratama, B. C., & Nugroho, A. (2020). Analisis Perbandingan Kinerja Keuangan Perusahaan Farmasi Sebelum dan Saat Pandemi Covid-19. Jurnal Ekonomi Dan Bisnis, 23(3), 450–468.
Ross, S. A., Westerfield, R. W., & Jordan, B. D. (2021). Fundamentals of Corporate Finance (13th ed.). McGraw-Hill Education.
Sari, M. P., & Utami, W. (2023). Resilience Strategy of Pharmaceutical Companies in Indonesia during the Covid-19 Pandemic: A Financial Perspective. Asian Journal of Accounting Research, 8(1), 78–92.
Sekaran, U., & Bougie, R. (2016). Research Methods for Business: A Skill-Building Approach (7th ed.). Wiley.
Sutton, T. (2020). Corporate Financial Accounting and Reporting (4th ed.). Pearson.
Titman, S., Keown, A. J., & Martin, J. D. (2021). FINANCIAL MANAGEMENT Principles and Applications FOURTEENTH GLOBAL EDITION. www.myfinancelab.com
Warfield, K. W. (2018). Intermediate Accounting IFRS Edition Third Edition (3rd ed.). https://app.box.com/s/43fggvlp5pyevbryvovkht9tngepmlmb
Weygandt, J. J., Kimmel, P. D., & Kieso, D. E. (2018). Financial Accounting with International Financial Reporting Standards (4th ed.). Wiley.
Yahoo Finance. (2023). Historical Financial Data for IDX-listed companies. Retrieved from finance.yahoo.com
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Amalina Nur Arifah, Andita Sulistyowati, Agniya Thahira
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
